Rhumbline Advisers Pulse Biosciences, Inc. Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 27,048 shares of PLSE stock, worth $532,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,048

Previous 27,375 1.19%

Holding current value

$532,304

Previous $440,000 7.27%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$14.48 - $19.27 $4,734 - $6,301	-327 Reduced 1.19%	27,048 $408,000
Q1 2025 Apr 08, 2025	BUY	$15.61 - $24.56 $25,194 - $39,639	1,614 Added 6.27%	27,375 $454,000
Q4 2024 May 29, 2025	SELL	$14.56 - $21.08 $23,499 - $34,023	-1,614 Reduced 5.9%	25,761 $476,000
Q4 2024 Jan 30, 2025	BUY	$14.56 - $21.08 $131 - $189	9 Added 0.03%	25,761 $476,000
Q3 2024 Nov 12, 2024	BUY	$10.83 - $21.83 $249 - $502	23 Added 0.09%	25,752 $451,000
Q2 2024 Aug 01, 2024	BUY	$6.69 - $14.54 $10,757 - $23,380	1,608 Added 6.67%	25,729 $287,000
Q1 2024 May 09, 2024	BUY	$7.8 - $11.02 $5,647 - $7,978	724 Added 3.09%	24,121 $210,000
Q4 2023 Feb 08, 2024	BUY	$3.85 - $12.84 $21,791 - $72,674	5,660 Added 31.91%	23,397 $286,000
Q3 2023 Nov 09, 2023	BUY	$4.03 - $8.73 $7,866 - $17,040	1,952 Added 12.37%	17,737 $71,000
Q2 2023 Aug 08, 2023	BUY	$3.67 - $8.64 $57,930 - $136,382	15,785 New	15,785 $113,000
Q2 2022 Aug 11, 2022	SELL	$1.48 - $4.28 $19,743 - $57,095	-13,340 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$4.21 - $14.79 $1,267 - $4,451	-301 Reduced 2.21%	13,340 $65,000
Q4 2021 Feb 10, 2022	SELL	$14.78 - $24.4 $3,724 - $6,148	-252 Reduced 1.81%	13,641 $202,000
Q3 2021 Nov 12, 2021	BUY	$17.25 - $26.63 $10,229 - $15,791	593 Added 4.46%	13,893 $300,000
Q2 2021 Aug 05, 2021	SELL	$16.31 - $23.64 $17,728 - $25,696	-1,087 Reduced 7.56%	13,300 $218,000
Q1 2021 May 06, 2021	SELL	$22.43 - $44.27 $25,570 - $50,467	-1,140 Reduced 7.34%	14,387 $341,000
Q4 2020 Feb 10, 2021	BUY	$11.66 - $24.5 $11,368 - $23,887	975 Added 6.7%	15,527 $370,000
Q3 2020 Nov 12, 2020	SELL	$9.27 - $13.14 $21,877 - $31,010	-2,360 Reduced 13.95%	14,552 $172,000
Q2 2020 Aug 13, 2020	BUY	$6.23 - $13.09 $15,668 - $32,921	2,515 Added 17.47%	16,912 $177,000
Q4 2019 Feb 05, 2020	BUY	$12.58 - $15.97 $855 - $1,085	68 Added 0.47%	14,397 $193,000
Q3 2019 Oct 23, 2019	SELL	$10.73 - $17.33 $1,126 - $1,819	-105 Reduced 0.73%	14,329 $221,000
Q2 2019 Aug 14, 2019	BUY	$11.11 - $17.34 $9,721 - $15,172	875 Added 6.45%	14,434 $191,000
Q1 2019 May 01, 2019	SELL	$11.69 - $19.44 $4,185 - $6,959	-358 Reduced 2.57%	13,559 $239,000
Q4 2018 Jan 31, 2019	BUY	$9.08 - $14.34 $126,366 - $199,569	13,917 New	13,917 $159,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.85M

Call Options Held

37.5K

Put Options Held

33.6K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $731M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Pulse Biosciences, Inc. Transaction History